Multifunctional magnetic nanoparticles for MRI-guided co-delivery of erlotinib and L-asparaginase to ovarian cancer

References

• Abdolahinia, E.D., et al., 2019. Enhanced penetration and cytotoxicity of metformin and collagenase conjugated gold nanoparticles in breast cancer spheroids. Life sciences. 231, 116545.
   PubMed Web of Science ®Google Scholar
• Aghanejad, A., et al., 2014. Radiosynthesis and biodistribution studies of [62Zn/62Cu]-plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging. Journal of radioanalytical and nuclear chemistry, 299 (3), 1635–1644.
   Web of Science ®Google Scholar
• Aghanejad, A., et al., 2016. Optimized production and quality control of 68Ga-DOTATATE. Iranian journal of nuclear medicine, 24 (1), 29–36.
   Google Scholar
• Aithal, A., et al., 2018. MUC16 as a novel target for cancer therapy. Expert opinion on therapeutic targets, 22 (8), 675–686.
   PubMed Web of Science ®Google Scholar
• Ajoolabady, A., et al., 2020. Enzyme-based autophagy in anti-neoplastic management: from molecular mechanisms to clinical therapeutics. Biochimica et biophysica acta - reviews on Cancer, 1874 (1), 188366.
   PubMed Web of Science ®Google Scholar
• Ali, A.A.A., et al., 2016. Erlotinib-conjugated iron oxide nanoparticles as a smart cancer-targeted theranostic probe for MRI. Scientific reports, 6, 36650.
   PubMed Web of Science ®Google Scholar
• Anisuzzaman, A.S.M., et al., 2017. In vitro and in vivo synergistic antitumor activity of the combination of BKM120 and erlotinib in head and neck cancer: mechanism of apoptosis and resistance. Molecular cancer therapeutics, 16 (4), 729–738.
   PubMed Web of Science ®Google Scholar
• Antonella, A., and Magnani, M., 2022. SPIO nanoparticles and magnetic erythrocytes as contrast agents for biomedical and diagnostic applications. Journal of magnetism and magnetic materials, 541, 168520.
   Web of Science ®Google Scholar
• Asgari, D., Aghanejad, A., and Mojarrad, J.S., 2011. An improved convergent approach for synthesis of erlotinib, a tyrosine kinase inhibitor, via a ring closure reaction of phenyl benzamidine intermediate. Bulletin of the Korean chemical society. 32 (3), 909–914.
   Web of Science ®Google Scholar
• Barghi, L., et al., 2012. Modified synthesis of erlotinib hydrochloride. Advanced pharmaceutical bulletin, 2 (1), 119–122.
   PubMedGoogle Scholar
• Boss, A., et al., 2022. Assessment of iron nanoparticle distribution in mouse models using ultrashort echo-time magnetic resonance imaging. NMR in biomedicine, 35 (6), e4690.
   PubMed Web of Science ®Google Scholar
• Cano, M., et al., 2017. Partial PEGylation of superparamagnetic iron oxide nanoparticles thinly coated with amine-silane as a source of ultrastable tunable nanosystems for biomedical applications. Nanoscale, 9 (2), 812–822.
   PubMed Web of Science ®Google Scholar
• Chou, T.-C., 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological reviews, 58 (3), 621–681.
   PubMed Web of Science ®Google Scholar
• Chou, T.C., and Talalay, P., 1981. Generalized equations for the analysis of inhibitions of Michaelis‐Menten and higher‐order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. European journal of biochemistry, 115 (1), 207–216.
   PubMedGoogle Scholar
• Cui, L., Xu, H., and Zhang, Y., 2022. Diagnostic accuracies of the ultrasound and magnetic resonance imaging ADNEX scoring systems for ovarian adnexal mass: systematic review and meta-analysis. Academic radiology, 29 (6), 897–908.
   PubMed Web of Science ®Google Scholar
• Effenberger, F.B., et al., 2017. Economically attractive route for the preparation of high quality magnetic nanoparticles by the thermal decomposition of iron (III) acetylacetonate. Nanotechnology, 28 (11), 115603.
   PubMed Web of Science ®Google Scholar
• Erol, A., Niemira, M., and Krętowski, A.J., 2019. Novel approaches in ovarian cancer research against heterogeneity, late diagnosis, drug resistance, and transcoelomic metastases. International journal of molecular sciences, 20 (11), 2649.
   PubMed Web of Science ®Google Scholar
• Evertsson, M., et al., 2017. Combined magnetomotive ultrasound, PET/CT, and MR imaging of 68 Ga-labelled superparamagnetic iron oxide nanoparticles in rat sentinel lymph nodes in vivo. Scientific reports, 7 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Foroughi-Nia, B., et al., 2021. Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors. Life sciences. 278, 119642.
   PubMed Web of Science ®Google Scholar
• Foroughi-Nia, B., et al., 2022. AS1411 conjugated magnetic-based poly N-isopropyl acrylamide nanoparticles for delivery of erlotinib to prostate cancer cells. Applied organometallic chemistry, 36 (7), e6691.
   Web of Science ®Google Scholar
• Garon, E.B., et al., 2018. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung cancer, 123, 91–98.
   PubMed Web of Science ®Google Scholar
• Giannakouros, P., et al., 2015. MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling. American journal of cancer research, 5 (1), 219–230.
   PubMed Web of Science ®Google Scholar
• He, Y., et al., 2016. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. Journal of controlled release, 229, 80–92.
   PubMed Web of Science ®Google Scholar
• Hejazi, M., et al., 2020. MicroRNA-193a and taxol combination: a new strategy for treatment of colorectal cancer. Journal of cellular biochemistry, 121 (2), 1388–1399.
   PubMed Web of Science ®Google Scholar
• Jabir, M.S., Nayef, U.M., and Kadhim, W.K.A., 2019. Polyethylene glycol-functionalized magnetic (Fe3O4) nanoparticles: a novel DNA-mediated antibacterial agent. Nano biomedicine & engineering, 11 (1), 18–27.
   Google Scholar
• Kadkhoda, J., et al., 2021. Advances in antibody nanoconjugates for diagnosis and therapy: a review of recent studies and trends. International journal of biological macromolecules, 185, 664–678.
   PubMed Web of Science ®Google Scholar
• Karimzadeh, I., et al., 2017. Saccharide-coated superparamagnetic Fe3O4 nanoparticles (SPIONs) for biomedical applications: an efficient and scalable route for preparation and in situ surface coating through cathodic electrochemical deposition (CED). Materials letters, 189, 290–294.
   Web of Science ®Google Scholar
• Khajeh, S., et al., 2018. Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells. Artificial cells, nanomedicine, and biotechnology, 46 (sup2), 1082–1090.
   PubMed Web of Science ®Google Scholar
• Li, H., et al., 2022. Sub-100 nm and ultra-thin hollow Gd2O3 nanospheres for effective magnetic resonance imaging T1 contrast agent. Journal of alloys and compounds, 897, 163190.
   Web of Science ®Google Scholar
• Loret, N., et al., 2019. The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance. Cancers, 11 (6), 838.
   PubMed Web of Science ®Google Scholar
• 5 - Mathematical models of drug release. In: M.L. Bruschi, ed. Strategies to modify the drug release from pharmaceutical systems. Amsterdam: Woodhead Publishing, 2015, 63–86.
   Google Scholar
• Madariaga, A., Lheureux, S., and Oza, A.M., 2019. Tailoring ovarian cancer treatment: implications of BRCA1/2 mutations. Cancers, 11 (3), 416.
   PubMed Web of Science ®Google Scholar
• Marinca, T., et al., 2016. Mechanosynthesis, structural, thermal and magnetic characteristics of oleic acid coated Fe3O4 nanoparticles. Materials chemistry and physics, 171, 336–345.
   Web of Science ®Google Scholar
• Mirzaei, A., et al., 2015. Preparation and evaluation of 68Ga-ECC as a PET renal imaging agent. Nuclear medicine and molecular imaging, 49 (3), 208–216.
   PubMedGoogle Scholar
• Moffitt, L., et al., 2019. Therapeutic targeting of collective invasion in ovarian cancer. International journal of molecular sciences, 20 (6), 1466.
   PubMed Web of Science ®Google Scholar
• Nabi, P.N., et al., 2021. Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer. International journal of biological macromolecules, 174, 185–197.
   PubMed Web of Science ®Google Scholar
• Napoletano, C., et al., 2019. Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets. Journal of clinical medicine, 8 (3), 380.
   PubMed Web of Science ®Google Scholar
• Panwar, V., et al., 2015. PEGylated magnetic nanoparticles (PEG@ Fe3O4) as cost effective alternative for oxidative cyanation of tertiary amines via CH activation. Applied catalysis A: general, 498, 25–31.
   Web of Science ®Google Scholar
• Prabha, G., and Raj, V., 2016. Preparation and characterization of polymer nanocomposites coated magnetic nanoparticles for drug delivery applications. Journal of magnetism and magnetic materials, 408, 26–34.
   Web of Science ®Google Scholar
• Raizer, J., et al., 2016. A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. Journal of neuro-oncology, 126 (1), 185–192.
   PubMed Web of Science ®Google Scholar
• Santala, E.E.E., et al., 2021. Antihypertensive drug use and the risk of ovarian cancer death among finnish ovarian cancer patients—a nationwide cohort study. Cancers, 13 (9), 2087.
   PubMed Web of Science ®Google Scholar
• Tarighatnia, A., et al., 2021. Engineering and quantification of bismuth nanoparticles as targeted contrast agent for computed tomography imaging in cellular and animal models. Journal of drug delivery science and technology, 66, 102895.
   Web of Science ®Google Scholar
• Tarighatnia, A., et al., 2021. Mucin-16 targeted mesoporous nano-system for evaluation of cervical cancerviadual-modal computed tomography and ultrasonography. New journal of chemistry, 45 (40), 18871–18880.
   Web of Science ®Google Scholar
• Tarighatnia, A., et al., 2022. Recent trends of contrast agents in ultrasound imaging: a review of the classifications and applications. Materials advances, 3 (9), 3726–3741.
   Web of Science ®Google Scholar
• Verma, A., and Stellacci, F., 2010. Effect of surface properties on nanoparticle–cell interactions. Small, 6 (1), 12–21.
   PubMed Web of Science ®Google Scholar
• Xie, X., et al., 2016. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. European journal of pharmaceutical sciences, 83, 28–35.
   PubMed Web of Science ®Google Scholar
• Yi, Y., et al., 2017. A smart, photocontrollable drug release nanosystem for multifunctional synergistic cancer therapy. ACS applied materials & interfaces, 9 (7), 5847–5854.
   PubMed Web of Science ®Google Scholar